1-6 of 6
Karin Fahl Wader
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer Christoffer El-Galaly, Jon Riise, Sirpa Leppä, Jacob Haaber Christensen, Karin Fahl Wader, Ingrid Glimelius
Journal: Blood
Blood (2022) 140 (Supplement 1): 184–185.
https://doi.org/10.1182/blood-2022-155654
Published: 2022
Journal Articles

Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Final Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial

Mats Jerkeman, MD PhD, Martin Hutchings, MD PhD, Riikka Räty, MD PhD, Karin Fahl Wader, MD PhD, Anna Laurell, MD PhD, Jacob H. Christensen, MD, Hanne Kuitunen, MD, Christian Winther Eskelund, MD PhD, Kirsten Groenbaek, MD DMSc, Carsten Utoft Niemann, MD PhD, Christian H. Geisler, MD PhD, Arne Kolstad, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-133298
Published: 2020
Journal Articles

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - Data from the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase I Trial: Stopping Treatment in Molecular Remission Is Feasible

Mats Jerkeman, MD PhD, Arne Kolstad, MD PhD, Carsten Utoft Niemann, MD PhD, Kirsten Groenbaek, MD DMSc, Martin Hutchings, MD PhD, Annika Pasanen, MD PhD, Sara Ekberg, Karin Fahl Wader, MD PhD, Ingrid Glimelius, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15.
https://doi.org/10.1182/blood-2020-133273
Published: 2020
Journal Articles

Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial

Mats Jerkeman, Martin Hutchings, Riikka Räty, Karin Fahl Wader, Anna Laurell, Hanne Kuitunen, Helle Toldbod, Lone Bredo Pedersen, Christian Winther Eskelund, Kirsten Grønbæk, Carsten Utoft Niemann, Christian H Geisler, Arne Kolstad
Journal: Blood
Blood (2016) 128 (22): 148.
https://doi.org/10.1182/blood.V128.22.148.148
Published: 2016
Journal Articles

Clinical and Biological Implications of BRAF V600E Mutation in Multiple Myeloma

Even Holth Rustad, Hong Yan Dai, PhD, Haakon Hov, MDPhD, Eivind Coward, PhD, Vidar Beisvag, PhD, Ola Myklebost, MDPhD, Eivind Hovig, PhD, Sigve Nakken, PhD, Daniel Vodák, Leonardo A Meza-Zepeda, PhD, Arne K Sandvik, MDPhD, Karin Fahl Wader, MD PhD, Kristine Misund, PhD, Anders Sundan, PhD, Harald Aarset, MDPhD, Anders Waage, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5685.
https://doi.org/10.1182/blood.V124.21.5685.5685
Published: 2014
Journal Articles

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

Brief Report
Olav Erich Yri, Dag Torfoss, Olav Hungnes, Anne Tierens, Kristian Waalen, Tone Nordøy, Susanne Dudman, Anette Kilander, Karin Fahl Wader, Bjørn Østenstad, Roald Ekanger, Peter Meyer, Arne Kolstad
Journal: Blood
Blood (2011) 118 (26): 6769–6771.
https://doi.org/10.1182/blood-2011-08-372649
Published: 2011